Skip to main content

Table 1 Clinical and biochemical data of symptomatic and asymptomatic female carriers

From: Genetic characterization in symptomatic female DMD carriers: lack of relationship between X-inactivation, transcriptional DMD allele balancing and phenotype

Carrier ID

Age at examination

Classification

Age at onset

Muscle weakness

Other signs

CK levels (U/l)

Echocardiogram

Muscle biopsy

        

Age at biopsy

Muscle

Muscle pathology

C1

5y8m

Symptomatic

2y

Yes: progressive, proximal, symmetric.

hCK No running, no jumping, positive Gowers sign

13430 at 6y

Normal

6y

Quadriceps

Moderate increase of endomysial fibrous tissue, moderate number of necrotic fibers, mild increase of internal nuclei, moderate number of hypercontracted fibers.

C2

34y

Symptomatic

na

Yes

hCK

1050 at 34y

Normal

34y

Tibialis anterior

Marked fiber size variation, moderate increase of endomysial fibrous tissue, increase of internal nuclei.

C3

4y

Symptomatic

4y

Yes: non progressive, proximal, symmetric. Main districts: limbs, trunk.

hCK Myalgia

2200 at 4y3m

nd

4y

Quadriceps

Rare internal nuclei.

C4

25y

Symptomatic

23y

Yes: progressive, proximal, asymmetric. Main districts: limbs, girdles.

hCK Calves hypertrophy Positive Gowers sign

3034 at 25y

nd

25y

Quadriceps

Marked fiber size variation, marked increase of endomysial fibrous tissue, some necrotic fibers.

C5

43y

Symptomatic

43y

Yes: progressive, proximal, symmetric. Main districts: limb girdles and distal muscles of lower limbs.

hCK

933 at 43y

nd

43y

Left deltoid

Moderate increase of endomysial fibrous tissue, marked fiber size variation, numerous internal nuclei.

C6

27y

Symptomatic

11y

Yes: progressive, proximal, symmetric. Main districts: girdles

hCK Anserine walking

714 at 27y

nd

27y

Quadriceps

Marked fiber size variation, increase of endomysial fibrous tissue, several internal nuclei, some necrotic fibers.

C7

9y

Symptomatic

na

Yes: symmetric, diffuse.

hCK Calves hypertrophy

6500 at 2y

nd

9y

Quadriceps

Moderate fiber size variation, several internal nuclei.

C8

20y

Asymptomatic

-

No

hCK Calves hypertrophy

>4000 at 7y

Normal

7y

Quadriceps

Moderate fiber size variation, hypotrophic fibers and degenerating-regenerating fibers.

C9

34y

Asymptomatic

-

No

hCK Mild calves hypertrophy

1654 at 16y

Normal

9y

Quadriceps

Mild myopathic signs.

C10

35y

Asymptomatic

-

No

hCK (at 32y and 35y)

Not reported

nd

35y

Quadriceps

Moderate fiber size variation.

C11

47y

Asymptomatic

-

No

hCK

899 at 47y

nd

47y

Quadriceps

Fiber size variation with hypertrophic fibers, internal nuclei.

C12

24y

Asymptomatic

-

No

hCK Calves hypertrophy

1295 at 24y

Normal

24y

Quadriceps

Very mild fiber size variation, some internal nuclei.

C13

21y

Asymptomatic

-

No

hCK Calves hypertrophy

10800 at 21y

Left ventricle at the upper limit

21y

Quadriceps

Moderate fiber size variation, increase of endomysial fibrous tissue, numerous internal nuclei, necrotic fibers.

C14

6y

Asymptomatic

-

No

hCK Myalgia

4439 at 6y

Normal

6y

Quadriceps

Fiber type variation, central nuclei, absence of inflammation.

C15

13y

Asymptomatic

-

No

hCK Learning difficulties

1732 at 13y

nd

13y

Quadriceps

Mild fiber size variation, increase in internal nuclei.

C16

17y

Asymptomatic

-

No

hCK Mild calves hypertrophy

2700 at 17y

nd

3y

Tibialis anterior

Dystrophic pattern.

C17

5y

Asymptomatic

-

No

hCK

8207 at 2y

Normal

2y

Quadriceps

Fiber size variation, mild increase of endomysial fibrous tissue, some groups of regenerating fibers.

C18

6y

Asymptomatic

-

No

hCK

10242 at 6y

Normal

6y

Quadriceps

Moderate increase of endomysial fibrous tissue, fiber size variation, several internal nuclei, some degenerating fibers.

  1. hCK: high CK; na: not available; nd: not determined.